SGP PHARMA ApS: Financial statements 2015
CVR: 35803173
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
SGP PHARMA ApS (CVR 35803173) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -167,002 and a net result of DKK -172,973. Equity in the 2015 report amounted to DKK -328,713.
- Gross Profit
- DKK -167,002
- Profit/Loss
- DKK -172,973
- Equity
- DKK -328,713
- Total Assets
- DKK 1,272,513
Official annual report
How creditworthy is SGP PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of August 7, 2015, Erik Vimalv is registered as director of SGP PHARMA ApS.
As of August 7, 2015, Malene Velbæk Kindlev has stepped down as direktion of SGP PHARMA ApS.
SGP PHARMA ApS has published its interim report for the period March 14, 2014 to December 31, 2014.
As of January 23, 2015, REVISIONSFIRMAET PER KRONBORG REGISTRERET REVISIONSANPARTSSELSKAB has been appointed auditor of SGP PHARMA ApS.
As of January 23, 2015, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of SGP PHARMA ApS.
About SGP PHARMA ApS
SGP PHARMA ApS was a Danish company of the type Anpartsselskab based in Allerød, founded in 2014. The company has been dissolved on 30 October 2018. The company was registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named MIR NUTRITIONAL PHARMA ApS. In 2015, the company reported a gross profit of DKK -167,002 and a net result of DKK -172,973. Equity in the 2015 report amounted to DKK -328,713.